Type 3 secretion effectors - Escherichia coli: Pathotypes and Principles of Pathogenesis - page 482

Schuller, S., Chong, Y., Lewin, J., Kenny, B., Frankel, G., Phillips, A.D., 2007. Tir phosphorylation
and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli
during ex vivo colonization of human intestinal mucosa is different to cell culture models. Cell.
Microbiol. 9 (5), 1352-1364 .
Schuller, S., Lucas, M., Kaper, J.B., Giron, J.A., Phillips, A.D., 2009. The ex vivo response of
human intestinal mucosa to enteropathogenic Escherichia coli infection. Cell Microbiol 11
(3), 521-530 .
Selbach, M., Paul, F.E., Brandt, S., et al., 2009. Host cell interactome of tyrosine-phosphorylated
bacterial proteins. Cell Host Microbe 5 (4), 397-403 .
Selyunin, A.S., Alto, N.M., 2011. Activation of PAK by a bacterial type III effector EspG reveals
alternative mechanisms of GTPase pathway regulation. Small GTPases. 2 (4), 217-221 .
Selyunin, A.S., Sutton, S.E., Weigele, B.A., et al., 2011. The assembly of a GTPase-kinase signal-
ling complex by a bacterial catalytic scaffold. Nature 469 (7328), 107-111 .
Sham, H.P., Shames, S.R., Croxen, M.A., et al., 2011. Attaching and effacing bacterial effector
NleC suppresses epithelial inlammatory responses by inhibiting NF-kappaB and p38 mitogen-
activated protein kinase activation. Infect. Immun. 79 (9), 3552-3562 .
Shames, S.R., Bhavsar, A.P., Croxen, M.A., et al., 2011. The pathogenic Escherichia coli type III
secreted protease NleC degrades the host acetyltransferase p300. Cell. Microbiol. 13 (10),
1542-1557 .
Shames, S.R., Croxen, M.A., Deng, W., Finlay, B.B., 2011. The type III system-secreted effector
EspZ localizes to host mitochondria and interacts with the translocase of inner mitochondrial
membrane 17b. Infect. Immun. 79 (12), 4784-4790 .
Shames, S.R., Deng, W., Guttman, J.A., et al., 2010. The pathogenic E. coli type III effector EspZ
interacts with host CD98 and facilitates host cell prosurvival signalling. Cell. Microbiol. 12 (9),
1322-1339 .
Shiflett, D.E., Clayburgh, D.R., Koutsouris, A., Turner, J.R., Hecht, G.A., 2005. Enteropathogenic
E. coli disrupts tight junction barrier function and structure in vivo. Lab. Invest. 85 (10),
1308-1324 .
Shifrin, Y., Kirschner, J., Geiger, B., Rosenshine, I., 2002. Enteropathogenic Escherichia coli
induces modiication of the focal adhesions of infected host cells. Cell. Microbiol. 4 (4),
235-243 .
Silverman, N., Maniatis, T., 2001. NF-kappaB signaling pathways in mammalian and insect innate
immunity. Genes Dev. 15 (18), 2321-2342 .
Simonovic, I., Rosenberg, J., Koutsouris, A., Hecht, G., 2000. Enteropathogenic Escherichia coli
dephosphorylates and dissociates occludin from intestinal epithelial tight junctions. Cell.
Microbiol. 2 (4), 305-315 .
Simpson, N., Shaw, R., Crepin, V.F., et al., 2006. The enteropathogenic Escherichia coli type III
secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diar-
rhoea. Mol. Microbiol. 60 (2), 349-363 .
Singer, A.U., Rohde, J.R., Lam, R., et al., 2008. Structure of the Shigella T3SS effector IpaH
deines a new class of E3 ubiquitin ligases. Nat. Struct. Mol. Biolo. 15 (12), 1293-1301 .
Smith, K., Humphreys, D., Hume, P.J., Koronakis, V., 2010. Enteropathogenic Escherichia coli
recruits the cellular inositol phosphatase SHIP2 to regulate actin-pedestal formation. Cell Host
Microbe 7 (1), 13-24 .
Starostina, N.G., Kipreos, E.T., 2012. Multiple degradation pathways regulate versatile CIP/KIP
CDK inhibitors. Trends Cell Biol. 22 (1), 33-41 .
Swanson, J.A., Johnson, M.T., Beningo, K., Post, P., Mooseker, M., Araki, N., 1999. A contractile
activity that closes phagosomes in macrophages. J. Cell Sci. 112 (Pt 3), 307-316 .